NEWLEPTÏL

Active material: Peritsiazin
When ATH: N05AC01
CCF: Antipsychotic drug (anxiolytic)
When CSF: 02.01.01.01
Manufacturer: AVENTIS Laboratories (France)

Pharmaceutical form, composition and packaging

Capsules hard gelatin, opaque, and the housing lid white; contents of capsules – yellow powder, practically odorless.

1 caps.
peritsiazin10 mg

Excipients: calcium hydrogen phosphate dihydrate, magnesium stearate.

10 PC. – blisters (5) – packs cardboard.

Oral solution 4% in the form of a transparent, fluorescent yellow-brown liquid with a smell of mint.

1 ml
peritsiazin40 mg

Excipients: tartaric acid, vitamin C, a concentrated sugar syrup, glycerol (glycerol), ethanol 95%, essential oil of peppermint, caramel (E150), Purified water.

125 ml – vials of dark glass (1) complete with a plastic syringe doser – packs cardboard.

 

Pharmacological action

Pharmacological action – antipsychotic, antispasmodic, antiemetic, sedation, snotvornoe. Blocks dopaminergic receptors (mainly D2), adrenergic, serotonergic, m-cholinergic receptors.

 

Testimony

  • psihopatii (excitable and hysterical type),
  • psychopathic disorders of organic origin with a predominance of affect and behavior sthenic,
  • psychopathic condition in schizophrenia (incl. geboidnye),
  • paranoid state within the organic, vascular, presenile and senile diseases;
  • epilepsy with affective-explosive characterological symptoms and dysphoric states.

Dosage regimen

Inside, at the beginning of treatment – 5-10 Mg (patients hypersensitive – 2-3 Mg) 3-4 Times daily, average daily dose – 30-40 Mg, maximum – 50-60 Mg.

 

Side effect

Oppression, dyskinesias: early (spasmodic torticollis, okulomotornыy crisis, Trizm) and late, extrapyramidal disorders; orthostatic hypotension, dry mouth, constipation, Parez akkomodacii, urinary retention, impotence, frigidity, amenorrhea, galactorrhea, gynecomastia, hyperprolactinemia, weight gain, hyperthermia, cholestatic jaundice, photosensitivity, agranulocytosis (rarely).

 

Contraindications

  • toxic agranulocytosis history,
  • zakrыtougolynaya glaucoma,
  • porphyria,
  • prostate adenoma.

Pregnancy and lactation

These are not represented.

 

Cautions

In the case of hyperthermia treatment should be stopped immediately.

Particularly careful monitoring is required in the treatment of epilepsy (in connection with a possible lowering epileptic threshold) and Parkinson's disease.

Carefully prescribed to elderly patients (sedation and hypotensive effects); cardiovascular diseases, kidney or liver failure; transport drivers and those, working with machinery (drowsiness and decreased, especially at the beginning of treatment, reaction).

 

Overdose

Data on overdose are not represented.

 

Drug Interactions

It enhances the effect of drugs, analgesics, ʙarʙituratov, alcohol, antihypertensives, trankvilizatorov.

 

Conditions and terms

Store at a temperature not exceeding 25 °C.

Shelf life – 5 years.

Back to top button